<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=8_Superior_Guidelines_For_CGK_733</id>
		<title>8 Superior Guidelines For CGK 733 - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=8_Superior_Guidelines_For_CGK_733"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=8_Superior_Guidelines_For_CGK_733&amp;action=history"/>
		<updated>2026-05-03T23:53:46Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=8_Superior_Guidelines_For_CGK_733&amp;diff=189123&amp;oldid=prev</id>
		<title>Cell0linda: Створена сторінка: &quot;&quot;To investigate carbohydrate (CARB) and supplementary fat/protein (CFP) counting using normal and dual-wave bolus in pump therapy of children and young people...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=8_Superior_Guidelines_For_CGK_733&amp;diff=189123&amp;oldid=prev"/>
				<updated>2017-06-14T11:19:25Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: &amp;quot;&amp;quot;To investigate carbohydrate (CARB) and supplementary fat/protein (CFP) counting using normal and dual-wave bolus in pump therapy of children and young people...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;quot;&amp;quot;To investigate carbohydrate (CARB) and supplementary fat/protein (CFP) counting using normal and dual-wave bolus in pump therapy of children and young people with type 1 diabetes (T1D). A randomized clinical trial was conducted in 42 patients (age 6�C21 yr) with T1D for at least 1 yr (5.2 �� 3.1 yr, mean �� SD) and pump therapy for at least 3 months (3.3 �� 1.8 yr). Standardized test meals (pizza-salami; 50% carbohydrate, 34% fat, 16% protein; corresponding to 33% of age-adjusted daily energy requirement) were given at lunch time on four different days with normal and dual-wave bolus using CARB and CFP counting in a randomized sequence. Sensor-augmented pumps were used for continuous glucose monitoring of 6-h postprandial glucose profiles. [http://www.selleckchem.com/products/ink128.html MLN0128 molecular weight] Intra-individual comparisons of glucose parameters [area under the curve (AUC) mg/dL ��6 h; average glucose, AV mg/dL] were performed. Using CFP counting, 6-h postprandial glucose AUC (805 �� 261) and AV (137.8 �� 46.2) were significantly lower than AUC (926 �� 285) and AV (160.5 �� 51.9) by CARB counting (p [http://en.wikipedia.org/wiki/Ataxia_telangiectasia_mutated CGK 733] 0.033). Postprandial hypoglycemia episodes ([http://www.selleckchem.com/products/OSI-906.html Linsitinib in vitro] 1,5-anhydroglucitrol, and continuous glucose monitoring. Objectives: To describe the interrelationships of glycemic control measures: hemoglobin A1c (HbA1c), glycated albumin, fructosamine, 1,5-anhydroglucitrol (1,5-AG), and continuous glucose monitoring (CGM) in children and adolescents with type 1 diabetes. Methods: In total, 26 subjects of age 4�C17 had HbA1c measurement followed within 14 d by three laboratory measures of glycemia and the collection of CGM glucose data (N = 21). Results: Glycated albumin and fructosamine levels had a higher correlation with each other than with HbA1c. The correlation of 1,5-AG with HbA1c was lower (absolute r value = 0.25). All four measures had a similar degree of correlation with CGM-measured mean glucose (absolute r value = 0.50�C0.56) and with hyperglycemic area under the curve (AUC) at 180 mg/dL (0.50�C0.60). Conclusion: Each of the four measures (i.e.&lt;/div&gt;</summary>
		<author><name>Cell0linda</name></author>	</entry>

	</feed>